Ziad A. Massy

1994–2025 年に発表

別表記
Ziad A Massy
230
論文数
35,470
被引用数
95
h 指数
216
i10 指数

被引用数

Ziad A. Massy の年別被引用数1966 年: 被引用 1 件1988 年: 被引用 1 件1990 年: 被引用 1 件1994 年: 被引用 1 件1996 年: 被引用 6 件1997 年: 被引用 19 件1998 年: 被引用 24 件1999 年: 被引用 41 件2000 年: 被引用 35 件2001 年: 被引用 47 件2002 年: 被引用 63 件2003 年: 被引用 55 件2004 年: 被引用 73 件2005 年: 被引用 82 件2006 年: 被引用 76 件2007 年: 被引用 78 件2008 年: 被引用 112 件2009 年: 被引用 121 件2010 年: 被引用 154 件2011 年: 被引用 210 件2012 年: 被引用 231 件2013 年: 被引用 240 件2014 年: 被引用 244 件2015 年: 被引用 234 件2016 年: 被引用 268 件2017 年: 被引用 256 件2018 年: 被引用 334 件2019 年: 被引用 1,137 件2020 年: 被引用 1,310 件2021 年: 被引用 1,449 件2022 年: 被引用 1,012 件2023 年: 被引用 769 件2024 年: 被引用 1,285 件2025 年: 被引用 646 件2026 年: 被引用 16 件1967〜1987 年は被引用が無いため表示していません1989 年は被引用が無いため表示していません1991〜1993 年は被引用が無いため表示していません1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,489 件、この内訳の 16.4%中国: 引用元論文 1,327 件、この内訳の 8.7%イギリス: 引用元論文 999 件、この内訳の 6.6%ドイツ: 引用元論文 868 件、この内訳の 5.7%イタリア: 引用元論文 827 件、この内訳の 5.4%フランス: 引用元論文 790 件、この内訳の 5.2%オランダ: 引用元論文 614 件、この内訳の 4%スペイン: 引用元論文 539 件、この内訳の 3.6%日本: 引用元論文 500 件、この内訳の 3.3%カナダ: 引用元論文 484 件、この内訳の 3.2%オーストラリア: 引用元論文 433 件、この内訳の 2.9%スウェーデン: 引用元論文 430 件、この内訳の 2.8%
0%16.4%その他 32.2%

分野

  • Medicine73%
  • Biochemistry, Genetics and Molecular Biology14.4%
  • Nursing2.7%
  • Immunology and Microbiology2.5%
  • Chemistry1.5%
  • Neuroscience1.3%
  • その他4.6%

トピック

  • Dialysis and Renal Disease Management10.3%
  • Chronic Kidney Disease and Diabetes6.4%
  • Parathyroid Disorders and Treatments4.4%
  • Acute Kidney Injury Research1.8%
  • Gut microbiota and health1.8%
  • Lipoproteins and Cardiovascular Health1.6%
  • その他73.7%

共著者

全論文

検索で開く
  1. Chronic kidney disease

    著者: , , , , , , , , - Nature Reviews Disease Primers 2017 被引用: 972

  2. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Lewis, William G. Herrington, Marion Mafham, William Majoni, Karl Wallendszus, Richard H. Grimm, Terje Pedersen, Jonathan A. Tobert, Jane Armitage, Alex Baxter, Christopher Bray, Yiping Chen, Zhengming Chen, Michael Hill, Carol Knott, Sarah Parish, David Simpson, Peter Sleight, Alan Young, Rory Collins - The Lancet 2011 被引用: 2,466

  3. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gloria Ashuntantang, Shakti Basnet, Aminu K. Bello, Worawon Chailimpamontree, Ricardo Correa‐Rotter, Jonathan C. Craig, Walter Douthat, Harold I. Feldman, Mohammad Reza Ganji, Guillermo García-García, Mohammed Benghanem Gharbi, David C.H. Harris, Vivekanand Jha, David W. Johnson, Rümeyza Kazancıoğlu, Robyn G. Langham, Zhi-Hong Liu, Ziad A. Massy, Masaomi Nangaku, Robert G. Nelson, Dónal O’Donoghue, Ikechi G. Okpechi, Roberto Pecoits‐Filho, Neil R. Powe, Giuseppe Remuzzi, Charlotte Roberts, Jérôme Rossert, Laura Solá, Bénédicte Stengel, Ernest K. Sumaili M, Yusuke Suzuki, Tetsuhiro Tanaka, Sajja Tatiyanupanwong, Bernadette Thomas, Katrin Uhlig, Robert G. Walker, S. L. White, Andrzej Więcek, Chih-Wei Yang - The Lancet 2017 被引用: 923

  4. Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association

    著者: , , , , , , , , , , , , , - Cardiovascular Research 2023 被引用: 314

  5. Classification of Uremic Toxins and Their Role in Kidney Failure

    著者: , , , , , , , , , , , , , , , - Clinical Journal of the American Society of Nephrology 2021 被引用: 282

  6. Review on uremic toxins: Classification, concentration, and interindividual variability

    著者: , , , , , , , , , , , , , , , , , , , , , , - Kidney International 2003 被引用: 1,672

  7. A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease

    著者: , , , , , , , , , , , , , , , , - Kidney International 2007 被引用: 1,954

  8. Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients

    著者: , , , , , , , , - Clinical Journal of the American Society of Nephrology 2009 被引用: 905

  9. The systemic nature of CKD

    著者: , , , , , , , , , , , , , , , - Nature Reviews Nephrology 2017 被引用: 438

  10. Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target

    著者: , , , , , - American Journal of Kidney Diseases 2015 被引用: 389

  11. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chuan‐Ming Hao, Kunitoshi Iseki, Joachim H. Ix, Kirsten L. Johansen, Markus Ketteler, Csaba P. Kövesdy, David E. Leaf, Iain C. Macdougall, Ziad A. Massy, Lawrence P. McMahon, Roberto Minutolo, Takeshi Nakanishi, Elizabeta Nemeth, Gregorio T. Obrador, Patrick S. Parfrey, Hyeong Cheon Park, Roberto Pecoits‐Filho, Bruce Robinson, Simon D. Roger, Yatrik Shah, Bruce Spinowitz, Tetsuhiro Tanaka, Yusuke Tsukamoto, Kriang Tungsanga, Carl P. Walther, Angela Yee‐Moon Wang, Myles Wolf - Kidney International 2021 被引用: 209

  12. Cognitive Disorders and Dementia in CKD

    著者: , , , , - Journal of the American Society of Nephrology 2013 被引用: 565

  13. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yoshitaka Isaka, Kunitoshi Iseki, Vivekanand Jha, Hideki Kawanishi, Peter G. Kerr, Paul Komenda, Csaba P. Kövesdy, E Lacson, Maurice Laville, Jung Pyo Lee, Edgar V. Lerma, Nathan W. Levin, Monika Lichodziejewska–Niemierko, Adrian Liew, Elizabeth Lindley, Robert S. Lockridge, Magdalena Madero, Ziad A. Massy, Linda McCann, Klemens B. Meyer, Rachael L. Morton, Annie-Claire Nadeau-Fredette, Hirokazu Okada, José J. Pérez, Jeff Perl, Kevan R. Polkinghorne, Miguel C. Riella, Bruce Robinson, Michael V. Rocco, Steven J. Rosansky, Joris I. Rotmans, María Fernanda Slon Roblero, Navdeep Tangri, Marcello Tonelli, Allison Tong, Yusuke Tsukamoto, Kriang Tungsanga, Tushar J. Vachharajani, Ismay van Loon, Suzanne Watnick, Daniel E. Weiner, Martin Wilkie, Elena Zakharova - Kidney International 2019 被引用: 420

  14. Diagnosis of cardiovascular disease in patients with chronic kidney disease

    著者: , , , , , , , , , , , , , - Nature Reviews Nephrology 2023 被引用: 75

  15. A Predictive Model for Progression of CKD to Kidney Failure Based on Routine Laboratory Tests

    著者: , , , , , , , , , , , , , , , , , , , , - American Journal of Kidney Diseases 2021 被引用: 79

  16. The role of phosphate in kidney disease

    著者: , , , , , , - Nature Reviews Nephrology 2016 被引用: 251

  17. p-Cresyl Sulfate Promotes Insulin Resistance Associated with CKD

    著者: , , , , , , , , , , , , - Journal of the American Society of Nephrology 2012 被引用: 266

  18. Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dimitrios Goumenos, Ayşe Tuğba Kartal, Laila‐Yasmin Mani, Hans-Peter Marti, Christopher Mayer, Rikke Nielsen, Vesna Pešić, Merita Rroji, Giorgos K. Sakkas, Goce Spasovski, Kate Stevens, Evgueniy Vazelov, Davide Viggiano, Lefteris C. Zacharia, Ana Carina Ferreira, Jolanta Malyszko, Ewout J. Hoorn, Andreja Figurek, Robert J. Unwin, Carsten A. Wagner, Christoph Wanner, Annette Bruchfeld, Marion Pépin, Andrzej Więcek, Dorothea Nitsch, Ivo Fridolin, Gaye Hafez, María José Soler Romeo, Michelangela Barbieri, Bojan Batinić, Laura Carrasco, Sol Carriazo, Ron T. Gansevoort, Gianvito Martino, Francesco Mattace‐Raso, Ionuţ Nistor, Alberto Ortíz, Giuseppe Paolisso, Daiva Rastenytė, Gabriel Ştefan, Gioacchino Tedeschi, Ziad A. Massy, Boris Bikbov, Karlhans Endlich, Olivier Godefroy, Jean‐Marc Chillon, Anastassia Kossioni, Justina Kurganaite, Norberto Perico, Giuseppe Remuzzi, Tomasz Grodzicki, Francesco Trepiccione, Carmine Zoccali, Mustafa Arıcı, Peter J. Blankestijn, Kai‐Uwe Eckardt, Danilo Fliser, Eugenio Gutiérrez Jiménez, Maximilian König, Ivan Rychlík, Michela Deleidi, György Reusz - Nephrology Dialysis Transplantation 2021 被引用: 90

  19. Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Melter, Christian Neusüß, Jan Novák, Karlheinz Peter, Kasper Rossing, Harald Rupprecht, Joost P. Schanstra, Eric Schiffer, Jens‐Uwe Stolzenburg, Lise Tarnow, Dan Theodorescu, Visith Thongboonkerd, Raymond Vanholder, Eva M. Weissinger, Harald Mischak, Philippe Schmitt‐Kopplin - Molecular & Cellular Proteomics 2010 被引用: 538

  20. Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease

    著者: , , , , , , , , - Kidney International 2009 被引用: 304

  21. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure

    著者: , , , , , , , , , , , , - The Lancet 2014 被引用: 434

  22. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA

    著者: , , , , , , , , , , , , , , , , , , , , , , - Nephrology Dialysis Transplantation 2020 被引用: 377

  23. Uremic Toxicity of Advanced Glycation End Products in CKD

    著者: , , , , - Journal of the American Society of Nephrology 2015 被引用: 233

  24. SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

    著者: , , , , , , , , , , , , , , , , , - Nephrology Dialysis Transplantation 2019 被引用: 204